Literature DB >> 22959541

Clinical presentation of deep vein thrombosis and pulmonary embolism.

Rupert M Bauersachs1.   

Abstract

BACKGROUND: In the past, the clinical diagnosis of venous thromboembolism (VTE), which comprises deep vein thrombosis (DVT) and pulmonary embolism (PE) had been very challenging, because clinical presentation is non-specific and inaccurate.
OBJECTIVE: To review and assess clinical signs, symptoms and risk factors of DVT and PE and identify most common differential diagnoses.
RESULTS: Important components for the clinical diagnosis of VTE include risk factors such as immobilization, presence of cancer, confinement to bed, previous major surgery, prior VTE and - specific for DVT - whole limb enlargement, one-sided calf enlargement and dilatation of superficial veins. Additional items specific for PE include tachycardia, dyspnea chest pain and hemoptysis. Many of these clinical characteristics are included into clinical prediction rules, such as the Wells pre-test probability score for DVT or PE or the Geneva score for PE. These scores are used to determine the pre-test probability for VTE and they constitute the basis for a diagnostic algorithm. Various clinical prediction rules for DVT or PE show comparable accuracy.
CONCLUSION: Even though the clinical presentation of DVT and PE varies substantially in individual patients and settings and may be misleading, diagnostic prediction rules based on clinical presentation and risk factors are very useful to assess pre-test probability, which is a very important concept for the diagnosis of DVT and PE.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22959541     DOI: 10.1016/j.beha.2012.07.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  4 in total

1.  Treacherous Travelers: Emboli.

Authors:  Scott J Cameron; Elixabeth Laskurain; Katarzyna Holcman; J Franklin Richeson; Hanna Mieszczanska
Journal:  Am J Med       Date:  2015-03-05       Impact factor: 4.965

2.  A Rare Case of Pulmonary Emboli Presenting With ST Elevation on ECG.

Authors:  Zaid Gheith; Bilal Alqam; Rajani Jagana
Journal:  Cureus       Date:  2022-09-16

3.  The use of factor Xa inhibitors following opening-wedge high tibial osteotomy for venous thromboembolism prophylaxis.

Authors:  Hideo Kobayashi; Yasushi Akamatsu; Ken Kumagai; Yoshihiro Kusayama; Ryo Ishigatsubo; Shota Mitsuhashi; Akihiro Kobayashi; Masato Aratake; Tomoyuki Saito
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-03-21       Impact factor: 4.342

4.  Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?

Authors:  Buğra Kerget; Dursun Erol Afşin; Alperen Aksakal; Seda Aşkin; Ömer Araz
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.